Posted Jun. 11, 2013 at 3:02 p.m.

Premium Lock BDSI opioid dependence drug on track for midsummer FDA filing

Published: 2013-06-11 15:02:23
Updated: 2013-06-11 15:02:23

How BDSI technology works How BDSI technology works

BioDelivery Sciences International (NASDAQ: BDSI) remains on track to file a new drug application in midsummer for Bunavail, the company’s maintenance treatment for opioid dependence....



Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll